等待开盘 06-09 09:30:00 美东时间
-0.500
-0.70%
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46
Morgan Stanley analyst Stephen Grambling maintains Travel+Leisure (NYSE:TNL) with a Overweight and lowers the price target from $80 to $78.
05-13 01:27
今日重点评级关注:花旗:维持Pegasystems"买入"评级,目标价从70美元升至71美元;巴克莱:维持曼哈顿联合软件"超配"评级,目标价从236美元升至239美元
04-24 12:10
Mizuho analyst Ben Chaiken maintains Travel+Leisure (NYSE:TNL) with a Outperform and lowers the price target from $107 to $105.
04-23 22:01
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Travel + Leisure业绩会实录,以下是Q3 2025财务业绩回顾摘要: ## 1. 财务业绩 **整体财务表现:** - 营收:10.4亿美元,同比增长5% - 调整后EBITDA:2.66亿美元,同比增长10% - 调整后每股收益:1.80美元,同比增长15% - 调整后自由现金流:同比增长23% **分业务板块表现:** - 度假所有权业务营收:8.76亿美元,同比增长6% - 度假所有权业务调整后EBITDA:2.31亿美元,同比增长14% - 旅游及会员业务营收:1.69亿美元,同比增长1% - 旅游及会员业务调整后EBITD
04-23 12:12
Tech stocks brushed new record highs during midday Wednesday, as a fresh wave of blockbuster corporate earnings propelled mega-cap technology and speculative names higher.
04-23 01:57
Travel Leisure shares are trading lower. The company reported Q1 financial resu...
04-23 00:27
华盛资讯4月22日讯,Travel Plus Leisure公布2026财年Q1业绩,公司Q1营收9.61亿美元,同比增长2.9%,归母净利润0.79亿美元,同比增长8.2%。
04-22 22:34
Companies Reporting Before The Bell • BankUnited (NYSE:BKU) is estimated to rep...
04-22 19:11
华盛资讯4月22日讯,Travel Plus Leisure公布2026财年Q1业绩,公司Q1营收9.61亿美元,同比增长2.9%,归母净利润0.79亿美元,同比增长8.2%。
04-22 18:48